These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 25962020)

  • 1. Calcineurin inhibitors: status quo and perspectives.
    Erdmann F; Weiwad M
    Biomol Concepts; 2011 Apr; 2(1-2):65-78. PubMed ID: 25962020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?
    Sieber M; Baumgrass R
    Cell Commun Signal; 2009 Oct; 7():25. PubMed ID: 19860902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity.
    Nelson PA; Akselband Y; Kawamura A; Su M; Tung RD; Rich DH; Kishore V; Rosborough SL; DeCenzo MT; Livingston DJ
    J Immunol; 1993 Mar; 150(6):2139-47. PubMed ID: 7680683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.
    Harding MW; Galat A; Uehling DE; Schreiber SL
    Nature; 1989 Oct; 341(6244):758-60. PubMed ID: 2477715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation.
    Clipstone NA; Crabtree GR
    Nature; 1992 Jun; 357(6380):695-7. PubMed ID: 1377362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel calcineurin inhibitor CN585 has potent immunosuppressive properties in stimulated human T cells.
    Erdmann F; Weiwad M; Kilka S; Karanik M; Pätzel M; Baumgrass R; Liebscher J; Fischer G
    J Biol Chem; 2010 Jan; 285(3):1888-98. PubMed ID: 19923214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitors of NFAT-calcineurin pathway].
    Miyatake S; Kaminuma O
    Nihon Rinsho; 2005 Sep; 63(9):1633-9. PubMed ID: 16164223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin mutants render T lymphocytes resistant to cyclosporin A.
    Zhu D; Cardenas ME; Heitman J
    Mol Pharmacol; 1996 Sep; 50(3):506-11. PubMed ID: 8794888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin inhibitors and Clostridium difficile infection in adult lung transplant recipients: the effect of cyclosporine versus tacrolimus.
    Lee JT; Whitson BA; Kelly RF; D'Cunha J; Dunitz JM; Hertz MI; Shumway SJ
    J Surg Res; 2013 Sep; 184(1):599-604. PubMed ID: 23566442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the immunosuppressive drugs CsA and FK506 on intracellular signalling and gene regulation.
    Rühlmann A; Nordheim A
    Immunobiology; 1997 Dec; 198(1-3):192-206. PubMed ID: 9442391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for calcineurin in degranulation of murine cytotoxic T lymphocytes.
    Dutz JP; Fruman DA; Burakoff SJ; Bierer BE
    J Immunol; 1993 Apr; 150(7):2591-8. PubMed ID: 7681074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II signalling and calcineurin in cardiac fibroblasts: differential effects of calcineurin inhibitors FK506 and cyclosporine A.
    White M; Montezano AC; Touyz RM
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):5-14. PubMed ID: 22184128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A promotes growth and invasiveness in vitro of human first-trimester trophoblast cells via MAPK3/MAPK1-mediated AP1 and Ca2+/calcineurin/NFAT signaling pathways.
    Du MR; Zhou WH; Dong L; Zhu XY; He YY; Yang JY; Li DJ
    Biol Reprod; 2008 Jun; 78(6):1102-10. PubMed ID: 18322274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin.
    Ryffel B; Weber E; Mihatsch MJ
    Exp Nephrol; 1994; 2(6):324-33. PubMed ID: 7532090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK506 and cyclosporin, molecular probes for studying intracellular signal transduction.
    Liu J
    Immunol Today; 1993 Jun; 14(6):290-5. PubMed ID: 7691065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
    Peng LK; Xie XB; Peng FH; Wang Y; Jiang Y; Lan GB; Fang CH; Nie MH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):59-62. PubMed ID: 17344588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive agents in organ transplantation: past, present, and future.
    Hong JC; Kahan BD
    Semin Nephrol; 2000 Mar; 20(2):108-25. PubMed ID: 10746855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
    Bozkaya G; Nart A; Uslu A; Onman T; Aykas A; Doğan M; Karaca B
    Transplant Proc; 2008; 40(1):151-5. PubMed ID: 18261573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A produces distal renal tubular acidosis by blocking peptidyl prolyl cis-trans isomerase activity of cyclophilin.
    Watanabe S; Tsuruoka S; Vijayakumar S; Fischer G; Zhang Y; Fujimura A; Al-Awqati Q; Schwartz GJ
    Am J Physiol Renal Physiol; 2005 Jan; 288(1):F40-7. PubMed ID: 15353404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.